Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Neurosurgery, Oslo University Hospital, Oslo, Norway.
PLoS One. 2022 Mar 8;17(3):e0264954. doi: 10.1371/journal.pone.0264954. eCollection 2022.
Although many patients report clinical improvement after surgery due to degenerative cervical myelopathy, the aim of intervention is to stop progression of spinal cord dysfunction. We wanted to provide estimates and assess achievement rates of Minimal Clinically Important Difference (MCID) at 3- and 12-month follow-up for Neck Disability Index (NDI), Numeric Rating Scale for arm pain (NRS-AP) and neck pain (NRS-NP), Euro-Qol (EQ-5D-3L), and European Myelopathy Score (EMS).
614 degenerative cervical myelopathy patients undergoing surgery responded to Patient-Reported Outcome Measures (PROMs) prior to, 3 and 12 months after surgery. External criterion was the Global Perceived Effect Scale (1-7), defining MCID as "slightly better", "much better" and "completely recovered". MCID estimates with highest sensitivity and specificity were calculated by Receiver Operating Curves for change and percentage change scores in the whole sample and in anterior and posterior procedural groups.
The NDI and NRS-NP percentage change scores were the most accurate PROMs with a MCID of 16%. The change score for NDI and percentage change scores for NDI, NRS-AP and NRS-NP were slightly higher in the anterior procedure group compared to the posterior procedure group, while remaining PROM estimates were similar across procedure type. The MCID achievement rates at 12-month follow-up ranged from 51% in EMS to 62% in NRS-NP.
The NDI and NRS-NP percentage change scores were the most accurate PROMs to measure clinical improvement after surgery for degenerative cervical myelopathy. We recommend using different cut-off estimates for anterior and posterior approach procedures. A MCID achievement rate of 60% or less must be interpreted in the perspective that the main goal of surgery for degenerative cervical myelopathy is to prevent worsening of the condition.
尽管许多患有退行性颈椎脊髓病的患者在手术后报告临床症状改善,但干预的目的是阻止脊髓功能障碍的进展。我们旨在提供颈椎脊髓病患者手术后 3 个月和 12 个月随访时 Neck Disability Index(NDI)、手臂疼痛数字评分量表(NRS-AP)和颈部疼痛(NRS-NP)、欧洲五维健康量表(EQ-5D-3L)和欧洲脊髓病评分(EMS)的最小临床重要差异(MCID)的估计值,并评估其达到率。
614 例接受手术治疗的退行性颈椎脊髓病患者在手术前、手术后 3 个月和 12 个月时对患者报告的结局测量(PROM)做出了回应。外部标准是全球感知效应量表(1-7),将 MCID 定义为“略有改善”、“明显改善”和“完全恢复”。通过整个样本和前路与后路手术组的变化和百分比变化评分的接收者操作曲线计算了具有最高敏感性和特异性的 MCID 估计值。
NDI 和 NRS-NP 的百分比变化评分是最准确的 PROM,其 MCID 为 16%。与后路手术组相比,前路手术组的 NDI 变化评分和 NDI、NRS-AP 和 NRS-NP 的百分比变化评分略高,而手术类型之间的其他 PROM 估计值相似。12 个月随访时,EMS 的 MCID 达标率为 51%,NRS-NP 为 62%。
NDI 和 NRS-NP 的百分比变化评分是衡量退行性颈椎脊髓病手术后临床改善的最准确的 PROM。我们建议对前路和后路手术分别使用不同的截止值估计。对于退行性颈椎脊髓病,手术的主要目标是防止病情恶化,因此 MCID 达标率为 60%或更低时必须从这一角度进行解读。